<DOC>
	<DOCNO>NCT01475240</DOCNO>
	<brief_summary>Use protease inhibitor associate elevation blood pigment call bilirubin . This may occasionally lead yellow eye ( scleral icterus ) jaundice , general population bilirubin elevation show antioxidant anti-inflammatory property could associate reduce risk cardiovascular disease event . Inflammation may also relevant neurocognitive impairment HIV ( Human Immunodeficiency Virus ) infection hence elevation bilirubin may also protective neurocognitive impairment . The purpose study evaluate impact hyperbilirubinemia ( HBR ) risk heart renal disease , cognitive function .</brief_summary>
	<brief_title>The Effect Hyperbilirubinemia CV Disease , Neurocog Function Renal Function</brief_title>
	<detailed_description>Use protease inhibitor associate unconjugated hyperbilirubinemia result inhibition UGT1A1 enzyme . Elevated level unconjugated bilirubin best characterize among individual Gilbert syndrome , common inherit cause unconjugated hyperbilirubinemia , present 3-10 % general population . Gilbert syndrome arises variant UGT1A1 enzyme , thus PIs induce biochemical picture similar Gilbert syndrome . Although elevation bilirubin may occasionally lead scleral icterus jaundice , cohort study individual Gilbert syndrome indicate bilirubin elevation may antioxidant anti-inflammatory property associate reduced risk cardiovascular event . Inflammation may also relevant cardiovascular ( CV ) risk , neurocognitive impairment renal disease HIV infection . This study seek investigate association antiretroviral associate HBR CV risk marker , neurocognitive impairment renal dysfunction</detailed_description>
	<mesh_term>Hyperbilirubinemia</mesh_term>
	<criteria>1 . The ability understand sign write informed consent form , prior participation screen procedure must willing comply study requirement . 2 . Documented HIV1 infection . 3 . &gt; 18 year age 4 . Stable PI base therapy TDF/FTC ABC/3TC &gt; 6 month either normal bilirubin bilirubin &gt; 2.5 X upper limit 5 . Stable &gt; 3 month lipid lower therapy , anticoagulant , hormone supplement , metformin ( lipohypertrophy ) metabolic therapies 6 . No known past history cardiovascular disease , neurocognitive disorder renal disease . 1 . Grade 12 Bilirubin 2 . Known CV disease ( angina , coronary artery disease , peripheral vascular disease , stroke , congestive cardiac failure myocardial dysfunction ) , Diabetes Mellitus , antihypertensive therapy 3 . Chronic NSAID use include low dose aspirin 4 . Known renal CNS neurocognitive disease 5 . HIV RNA &gt; 400copies/ml last 6 month 6 . Change antiretroviral Therapy last 6 month 7 . Active Hepatitis B ( sAg +ve ) hepatitis C ( detectable HCV RNA , , treat cleared Hepatitis C permit infection and/or treatment &gt; 6months previous ) 8 . Use anabolic steroid . Cutaneous administer testosterone supplement stable &gt; 3 month document hypogonadism permit . Oral contraceptive stable 3 month permit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>HIV</keyword>
</DOC>